Docetaxel and bortezomib downregulate Bcl-2 and sensitize PC-3-Bcl-2 expressing prostate cancer cells to irradiation

被引:0
作者
Wengang Cao
Kathleen T. Shiverick
Kazunori Namiki
Yoshihisa Sakai
Stacy Porvasnik
Cydney Urbanek
Charles J. Rosser
机构
[1] University of Florida College of Medicine,Department of Urology
[2] University of Florida,Department of Pharmacology and Therapeutics
来源
World Journal of Urology | 2008年 / 26卷
关键词
Docetaxel; Bortezomib; Radiation; Prostate cancer; -2;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 101 条
[1]  
Jemal A(2007)Cancer statistics CA Cancer J Clin 57 43-66
[2]  
Siegel R(1997)Prostate cancer incidence and mortality rates among white and black men Epidemiology 8 126-131
[3]  
Ward E(1995)Advanced prostate cancer: the results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone Int J Radat Oncol Biol Phys 32 3-12
[4]  
Merrill RM(1996)Conventional vs. conformal radiotherapy for prostate cancer. Preliminary results of dosimetry and acute toxicity Int J Radiat Oncol Biol Phys 34 555-564
[5]  
Brawley OW(1993)Prostate cancer. Radiation therapy for localized disease Cancer 71 939-952
[6]  
Shipley WU(2000)Preliminary results of a randomized radiotherapy dose-escalation study comparing 70 Gy with 78 Gy for prostate cancer J Clin Oncol 18 3904-3911
[7]  
Verhey LJ(1981)Complications of definitive radiotherapy for carcinoma of the prostate Int. J Radiat Oncol Biol Phys 7 1341-1348
[8]  
Munzenrider JE(1994)Treatment-related sequelae following external beam radiation for prostate cancer: a review with an update in patients with stage T1 and T2 tumors J Urol 152 1799-1805
[9]  
Pollack A(2007)Overcoming the radioresistance of prostate cancer cells with a novel Bcl-2 inhibitor Oncogene 26 652-661
[10]  
Zagars GK(1998)bcl-2/bax ratio as a predictive marker for therapeutic response to radiotherapy in patients with prostate cancer Urology 52 1085-1090